1.Guidance of instructions for compiling expert consensus on clinical practice of Chinese patent medicine of China Association of Chinese Medicine.
Mei MO ; Xiao-Xiao ZHANG ; Xing LIAO ; Bo LI ; Wei CHEN ; Guo-Zhen ZHAO ; Yu-Bo GUO
China Journal of Chinese Materia Medica 2019;44(12):2652-2656
The expert consensus on clinical practice of Chinese patent medicines shall be regarded as the same with clinical practice guidelines,which shall be concise,readable and applicable. Therefore,a formal expert consensus is unable to contain the whole compilation process and the content of its important process documents. It is necessary to write instructions for continuation,expansion and publicity. In 2018 Standardization Department of China Association of Chinese Medicine invited methodologists with the background of evidence-based medicine drafted a series of standards for expert consensus on clinical practice of Chinese patent medicines,including the guidance for compilation the instructions. It will be useful for readers of expert consensus to understand the work behind the compilation,so as to make the compilation process more transparent and standardized. We proposed nine requirements for compilation the instructions,namely content and requirements,work overview,main technical content,compilation process,process and basis for handling major disagreements,expert consensus implementation requirements and measure suggestions,other issues need to be explained,appendix and format for instructions.
China
;
Consensus
;
Evidence-Based Medicine
;
Medicine, Chinese Traditional
;
standards
;
Nonprescription Drugs
;
standards
2.Reporting standards for expert consensus on clinical practice of Chinese patent medicines of China Association of Chinese Medicine.
Mei MO ; Xing LIAO ; Xiao-Xiao ZHANG ; Bo LI ; Wei CHEN ; Guo-Zhen ZHAO ; Yu-Bo GUO
China Journal of Chinese Materia Medica 2019;44(12):2644-2651
In 2018,Standardization Department of China Association of Chinese Medicine invited methodologists with the background of evidence-based medicine to discuss and draft a series of standards for expert consensus on clinical practice of Chinese patent medicines. These standards have been made by reference to the published standards for developing expert consensus and clinical practice guidelines. These standards were made based on full consideration of the current evidence status and the history of clinical practice of Chinese patent medicines. These standards were composed of four parts,namely information summary items,normative general items,normative technical items and information supplementary items,including cover,content,preface,introduction,title,scope,basic Information of Chinese patent medicine,suggestions for clinical application,safety,conflict of interest,appendix,and references,so as to provides reference for improving the quality of expert consensus-based compilation and enhancing the applicability of expert consensus.
China
;
Consensus
;
Evidence-Based Medicine
;
Humans
;
Medicine, Chinese Traditional
;
standards
;
Nonprescription Drugs
;
standards
3.Introduction on 'assessing the risk of bias of individual studies' in systematic review of health-care intervention programs revised by the Agency for Healthcare Research and Quality.
J C YANG ; Z R YANG ; S Q YU ; S Y ZHAN ; F SUN
Chinese Journal of Epidemiology 2019;40(1):106-111
This paper summarizes the Risk of Bias of Individual Studies in Systematic Reviews of Health Care Interventions revised by the Agency for Healthcare Research and Quality (AHRQ) and introduces how to use Revman software make risk of bias graph or risk of bias summary. AHRQ tool can be used to evaluate following study designs: RCTs, cohort study, case-control study (including nested case-control), case series study and cross-sectional study. The tool evaluates the risk of bias of individual studies from selection bias, performance bias, attrition bias, detection bias and reporting bias. Each of the bias domains contains different items, and each item is available for the assessment of one or more study designs. It is worth noting that the appropriate items should be selected for evaluation different study designs instead of using all items to directly assess the risk of bias. AHRQ tool can be used to evaluate risk of bias individual studies when systematic reviews of health care interventions is including different study designs. Moreover, the tool items are relatively easy to understand and the assessment process is not complicated. AHRQ recommends the use of high, medium and low risk classification methods to assess the overall risk of bias of individual studies. However, AHRQ gives no recommendations on how to determine the overall bias grade. It is expected that future research will give corresponding recommendations.
Bias
;
Evidence-Based Medicine/standards*
;
Health Services Research
;
Systematic Reviews as Topic
4.Ministry of Health Clinical Practice Guidelines: Chronic Obstructive Pulmonary Disease.
Tow Keang LIM ; Cynthia B CHEE ; Patsy CHOW ; Gerald Sw CHUA ; Soo Kiang ENG ; Soon Keng GOH ; Kwee Keng KNG ; Wai Hing LIM ; Tze Pin NG ; Thun How ONG ; S T Angeline SEAH ; Hsien Yung TAN ; K H TEE ; Vimal PALANICHAMY ; Meredith T YEUNG
Singapore medical journal 2018;59(2):76-86
The Ministry of Health (MOH) has updated the Clinical Practice Guidelines on Chronic Obstructive Pulmonary Disease (COPD) to provide doctors and patients in Singapore with evidence-based treatment for COPD. This article reproduces the introduction and executive summary (with recommendations from the guidelines) from the MOH Clinical Practice Guidelines on COPD, for the information of SMJ readers. Chapters and page numbers mentioned in the reproduced extract refer to the full text of the guidelines, which are available from the Ministry of Health website: https://www.moh.gov.sg/content/moh_web/healthprofessionalsportal/doctors/guidelines/cpg_medical.html. The recommendations should be used with reference to the full text of the guidelines. Following this article are multiple choice questions based on the full text of the guidelines.
Adult
;
Aged
;
Evidence-Based Medicine
;
Humans
;
Middle Aged
;
Palliative Care
;
Prevalence
;
Pulmonary Disease, Chronic Obstructive
;
diagnosis
;
therapy
;
Pulmonary Medicine
;
standards
;
Quality Improvement
;
Radiography, Thoracic
;
Risk Factors
;
Singapore
;
Steroids
;
therapeutic use
5.Development and future of minimally invasive surgery in western China.
Chinese Journal of Gastrointestinal Surgery 2017;20(3):244-246
There are vast land and lots of people in western China, but the economy developing is relatively slow. However, the minimally invasive surgery was carried out firstly in China. Moreover, the type, number and difficulty of the minimally invasive surgery increased year by year. Especially, in the western area of China, Dr Zhou Zongguang, Yu Peiwu and Zheng Shuguo et al. have performed much pioneering work in laparoscopic surgery for rectal cancer, gastric cancer and laparoscopic liver resection. They led the standard development of minimally invasive in China. In the future, western China should continue to strengthen the standardized training of minimally invasive surgery, make great effort to carry out evidence-based research of minimally invasive surgery, provide evidences of high level of clinical application in minimally invasive surgery. At the same time, we should carry out the robotic and 3D laparoscopic surgery actively, leading the development of minimally invasive surgery more standardized and more widespread in western China.
China
;
Digestive System Surgical Procedures
;
methods
;
trends
;
Evidence-Based Medicine
;
Hepatectomy
;
methods
;
Humans
;
Laparoscopy
;
methods
;
Minimally Invasive Surgical Procedures
;
education
;
methods
;
standards
;
trends
;
Rectal Neoplasms
;
surgery
;
Robotic Surgical Procedures
;
Stomach Neoplasms
;
surgery
6.Multidisciplinary team improves the comprehensive quality of colorectal surgeons.
Xinyu QIN ; Jianmin XU ; Qingyang FENG
Chinese Journal of Gastrointestinal Surgery 2017;20(1):18-20
Colorectal cancer is a systemic disease that requires multidisciplinary treatment. The comprehensive quality of colorectal surgeon directly impacts on the efficacy of diagnosis and treatment of colorectal cancer. Multidisciplinary teams help surgeons enhance their ability of evidence-based medicine, improve the quality of main specialty, expand the knowledge of other specialty, enhance the doctor-patient communication, and increase the research level. Thus, multidisciplinary teams can improve the comprehensive quality of colorectal surgeons.
Colorectal Neoplasms
;
diagnosis
;
therapy
;
Colorectal Surgery
;
Communication
;
Evidence-Based Medicine
;
methods
;
Humans
;
Interdisciplinary Communication
;
Patient Care Team
;
standards
;
Physician-Patient Relations
;
Quality of Health Care
;
Surgeons
;
standards
7.Explanation of Evidence-based Guidelines of Clinical Practice with Acupuncture and Moxibustion: Adult Bronchial Asthma.
Yue JIAO ; Zhongchao WU ; Wenna ZHOU ; Xiaohua SI ; Jingjing WANG ; Jincao ZHOU ; Zhongjie CHEN ; Rongjun LI ; Xiaoguang ZHAO ; Liwei XIAO
Chinese Acupuncture & Moxibustion 2016;36(5):529-531
The development and compilation of Evidence-based Guidelines of Clinical Practice with Acupuncture and Moxibustion: Adult Bronchial Asthma are introduced from three aspects, named the guideline methodology, the guideline structure and the guideline content. Based on the acupuncture-moxibustion practice and clinical research, the evidence-based medicine method is adopted. During the development and compilation of the guideline, the characteristics and advantages of acupuncture and moxibustion are specially considered in the treatment of this disease; the latest optimum evidences at home and abroad, experts' experience and patients' value are closely integrated with each other. Additionally, the worldwide accepted assessments of evidence quality and the recommendation (GRADE system) are combined with the clinical evidences of the ancient and modern famous acupuncture-moxibustion experts, and the clinical research evidences are with the experts' consensus to the large extent. The purpose of the guideline is to provide the maximal guidance to the clinical physicians.
Asthma
;
therapy
;
Evidence-Based Medicine
;
standards
;
Humans
;
Moxibustion
;
standards
;
Practice Guidelines as Topic
;
Reference Books
8.The Korean guideline for cervical cancer screening.
Kyung Jin MIN ; Yoon Jae LEE ; Mina SUH ; Chong Woo YOO ; Myong Cheol LIM ; Jaekyung CHOI ; Moran KI ; Yong Man KIM ; Jae Weon KIM ; Jea Hoon KIM ; Eal Whan PARK ; Hoo Yeon LEE ; Sung Chul LIM ; Chi Heum CHO ; Sung Ran HONG ; Ji Yeon DANG ; Soo Young KIM ; Yeol KIM ; Won Chul LEE ; Jae Kwan LEE
Journal of Gynecologic Oncology 2015;26(3):232-239
The incidence rate of cervical cancer in Korea is still higher than in other developed countries, notwithstanding the national mass-screening program. Furthermore, a new method has been introduced in cervical cancer screening. Therefore, the committee for cervical cancer screening in Korea updated the recommendation statement established in 2002. The new version of the guideline was developed by the committee using evidence-based methods. The committee reviewed the evidence for the benefits and harms of the Papanicolaou test, liquid-based cytology, and human papillomavirus (HPV) testing, and reached conclusions after deliberation. The committee recommends screening for cervical cancer with cytology (Papanicolaou test or liquid-based cytology) every three years in women older than 20 years of age (recommendation A). The cervical cytology combined with HPV test is optionally recommended after taking into consideration individual risk or preference (recommendation C). The current evidence for primary HPV screening is insufficient to assess the benefits and harms of cervical cancer screening (recommendation I). Cervical cancer screening can be terminated at the age of 74 years if more than three consecutive negative cytology reports have been confirmed within 10 years (recommendation D).
Adult
;
Age Factors
;
Aged
;
Early Detection of Cancer/adverse effects/*methods/standards
;
Evidence-Based Medicine
;
False Positive Reactions
;
Female
;
Humans
;
Hysterectomy
;
Middle Aged
;
Papillomavirus Infections/diagnosis
;
Papillomavirus Vaccines
;
Patient Selection
;
Pregnancy
;
Pregnancy Complications, Neoplastic/diagnosis
;
Republic of Korea
;
Review Literature as Topic
;
Uterine Cervical Neoplasms/*diagnosis
;
Vaginal Smears/adverse effects/methods/standards
;
Young Adult
10.Study on the methodology of developing evidence-based clinical practice guidelines of Chinese medicine.
Zheng-guang CHEN ; Hui LUO ; Shan XU ; Yan YANG ; Shou-chuan WANG
Chinese journal of integrative medicine 2015;21(11):874-880
At present, evidence-based clinical practice guideline (EBCPG) is the main mode of developing clinical practice guidelines (CPGs) in the world, but in China, most of CPGs of Chinese medicine (CM) are still guidelines based on expert consensus. The objective of this study is to construct initially the methodology of developing EBCPGs of CM and to promote the development of standardization of CM. Based on the development of "Guideline for Diagnosis and Treatment of Common Pediatric Diseases in CM", the methodology of developing EBCPG of CM was explored by analyzing the pertinent literature and considering the characteristics of CM. In this study, the key problem was to put forward the suggestion and strategies. However, due to the methodology study of developing EBCPG of CM is still in the initial stage, there are still some problems which need further study.
Delphi Technique
;
Evaluation Studies as Topic
;
Evidence-Based Medicine
;
Medicine, Chinese Traditional
;
standards
;
Practice Guidelines as Topic

Result Analysis
Print
Save
E-mail